Search
IRadimed Corp
IRMDAdd to Watchlist
85.400USD
+0.100+0.12%
Close 10-02 16:00（ET）
1.09BMarket Cap
46.06P/E TTM
IRadimed Corp (IRMD) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to IRadimed Corp in the past month.
Buy
0 Strong Buy
2 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
118.000USD+38.17%
IRMD Analyst Recommendation Trends
In the current month, IRMD has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IRMD average Analyst price target in the last month is 118.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
2
2
3
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
3
2
2
2
2
2
IRMD Analyst Rating for Peer Comparison
Updated: Oct 4, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Intuitive Surgical Inc
ISRG
10
14
9
1
0
34
Boston Scientific Corp
BSX
11
17
6
0
0
34
Thermo Fisher Scientific Inc
TMO
10
16
6
0
0
32
Veeva Systems Inc
VEEV
8
14
7
1
0
30
Edwards Lifesciences Corp
EW
10
14
6
0
0
30
Danaher Corp
DHR
11
13
4
0
0
28
Waters Corp
WAT
8
10
9
0
0
27
Agilent Technologies Inc
A
6
10
7
0
0
23
Illumina Inc
ILMN
5
7
7
2
1
22
Resmed Inc
RMD
2
7
10
1
1
21
Financial Forecasting
Based on analysts' estimates, IRMD EPS is projected to reach 0.548 in FY2026Q3, following reported EPS of 0.408 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.48
0.45
0.42
0.55
0.63
Actual
0.51
0.46
0.41
--
--
Surprise
+5.37%
+2.28%
-2.82%
--
--
FAQs
What is IRadimed Corp's expected revenue for the next quarter?
IRadimed Corp's expected revenue is 23.43M.
What is IRadimed Corp's price target?
Analysts forecast that IRadimed Corp's price target is USD 118.00, with the highest forecast at USD 120.00 and the lowest forecast at USD 116.00.
How have IRadimed CorpIRMD's recent earnings per share performed?
The market expectation was USD 0.41, while IRadimed CorpIRMD's earnings per share (EPS) for the previous quarter was USD 0.46. EPS for the next quarter is expected at USD 0.55.
What is the analyst rating for IRadimed Corp?
Based on the ratings of IRadimed Corp's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.